Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 26, 2021
Response to Letter to the Editor
Makoto Nishio, Diana Mendus, Lijia Wang, et al.
The European Journal of Neuroscience
|
January 28, 2014
Thrombospondins 1 and 2 are important for afferent synapse formation and function in the inner ear
Diana Mendus, Srividya Sundaresan, Nicolas Grillet, et al.
Plos One
|
May 9, 2014
A lack of immune system genes causes loss in high frequency hearing but does not disrupt cochlear synapse maturation in mice
Melissa A Calton, Dasom Lee, Srividya Sundaresan, et al.
Journal for Immunotherapy of Cancer
|
March 19, 2021
Fast progression in non-small cell lung cancer: results from the randomized phase III OAK study evaluating second-line atezolizumab versus docetaxel
David Gandara, Martin Reck, Denis Moro-Sibilot, et al.
Molecular Oncology
|
February 11, 2020
Diphenhydramine increases the therapeutic window for platinum drugs by simultaneously sensitizing tumor cells and protecting normal cells
Margarita Melnikova, Ulrike Sophie Wauer, Diana Mendus, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 17, 2020
Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial
Makoto Nishio, Fabrice Barlesi, Howard West, et al.
Journal of Clinical Pharmacology
|
December 18, 2023
Pharmacokinetics (PK) of Tiragolumab in First-in-Human Study in Patients with Mixed Solid Tumors (GO30103)
Elena Garralda, Do Youn Oh, Antoine Italiano, et al.
Genes & Development
|
April 17, 2010
Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer
Trudy G Oliver, Kim L Mercer, Leanne C Sayles, et al.
JAMA Oncology
|
September 28, 2023
Anti-TIGIT Antibody Tiragolumab Alone or With Atezolizumab in Patients With Advanced Solid Tumors: A Phase 1a/1b Nonrandomized Controlled Trial
Tae Won Kim, Philippe L Bedard, Patricia LoRusso, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 26, 2021
Response to Letter to the Editor
Makoto Nishio, Diana Mendus, Lijia Wang, et al.
The European Journal of Neuroscience
|
January 28, 2014
Thrombospondins 1 and 2 are important for afferent synapse formation and function in the inner ear
Diana Mendus, Srividya Sundaresan, Nicolas Grillet, et al.
Plos One
|
May 9, 2014
A lack of immune system genes causes loss in high frequency hearing but does not disrupt cochlear synapse maturation in mice
Melissa A Calton, Dasom Lee, Srividya Sundaresan, et al.
Journal for Immunotherapy of Cancer
|
March 19, 2021
Fast progression in non-small cell lung cancer: results from the randomized phase III OAK study evaluating second-line atezolizumab versus docetaxel
David Gandara, Martin Reck, Denis Moro-Sibilot, et al.
Molecular Oncology
|
February 11, 2020
Diphenhydramine increases the therapeutic window for platinum drugs by simultaneously sensitizing tumor cells and protecting normal cells
Margarita Melnikova, Ulrike Sophie Wauer, Diana Mendus, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 17, 2020
Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial
Makoto Nishio, Fabrice Barlesi, Howard West, et al.
Journal of Clinical Pharmacology
|
December 18, 2023
Pharmacokinetics (PK) of Tiragolumab in First-in-Human Study in Patients with Mixed Solid Tumors (GO30103)
Elena Garralda, Do Youn Oh, Antoine Italiano, et al.
Genes & Development
|
April 17, 2010
Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer
Trudy G Oliver, Kim L Mercer, Leanne C Sayles, et al.
JAMA Oncology
|
September 28, 2023
Anti-TIGIT Antibody Tiragolumab Alone or With Atezolizumab in Patients With Advanced Solid Tumors: A Phase 1a/1b Nonrandomized Controlled Trial
Tae Won Kim, Philippe L Bedard, Patricia LoRusso, et al.
Page
of 1